David (Wei Fu) Li

We advised the underwriters on the investment-grade debt offering

We advised the underwriters on the equity offering

We advised the placement agent on the private placement of stock and warrants

We advised the underwriters on the equity offering

We advised Amwell on the stock offering

We advised the underwriters on the SPAC IPO and NYSE listing

Davis Polk advised the sole book-running manager in connection with the $80 million initial public offering of 8,000,000 units of Consonance-HFW Acquisition Corp. Each unit consists of…

Davis Polk advised the sales agents in connection with an SEC-registered at-the-market offering by BioNTech SE of its ordinary shares represented by American depositary shares for up to an…

Davis Polk advised Gatos Silver, Inc. on its SEC-registered initial public offering of 21,430,000 common shares for total gross proceeds of approximately $150 million. In addition, Gatos…

 Davis Polk advised ADC Therapeutics SA on its SEC-registered offering of 6,000,000 common shares for total gross proceeds of $204 million. ADC Therapeutics is listed on the New York…